A Deep Dive into Drug Discovery Services Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034

How Are the key drivers contributing to the expansion of the drug discovery services market?
The escalating emphasis on drug discovery investigations is projected to fuel the growth of the drug discovery services sector. The drug development process plays a pivotal role in securing the safe and efficient delivery of drugs, thus leading to the rising prominence of clinical trials as a crucial element of it. Given the mounting significance of drug development and innovation in the healthcare industry, the demand for drug discovery trials globally is on the upswing. For example, ClinicalTrials.gov, a hub for registering clinical trials, recorded 452,604 trials in May 2023, marking an upturn from the 365,000 trials reported in 2021. Consequently, the intensified focus on drug discovery investigations is poised to stimulate the expansion of the drug discovery services market.

Get Your Drug Discovery Services Market Report Here:
https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

What growth opportunities are expected to drive the drug discovery services market's CAGR through 2034?
The market size for drug discovery services has seen a rapid expansion in the past few years. The market is set to grow from $18.27 billion in 2024 to $20.59 billion in 2025, with a compound annual growth rate (CAGR) of 12.7%. Factors contributing to this growth during the historical period include heightened R&D expenditure, an increasing disease burden, government financing and backing, the rise of contract research organizations (CROs), a shift towards individualized medicine, and drug repurposing strategies.

In the forthcoming years, the market size for drug discovery services is anticipated to experience significant expansion. It is projected to escalate to $33.88 billion by 2029, boasting a compound annual growth rate (CAGR) of 13.3%. The predicted growth during this period can be ascribed to alterations in the regulatory framework, progress in drug delivery systems, intensifying interest in immunotherapy, a shift towards RNA-based therapeutics, and a focus on rare diseases. The forecast period will also see key trends such as the adoption of advanced technologies, the proliferation of biologicals and biopharmaceuticals, the implementation of high-throughput screening, advancements in virtual screening, and an emphasis on regenerative medicine.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8324&type=smp

What are the emerging trends shaping the future of the drug discovery services market?
Leading businesses in the drug discovery services market, such as Eurofins Discovery, are pioneering advanced technologies like artificial intelligence (AI) and machine learning (ML) to improve the proficiency and precision of drug discovery. AI and ML are intertwined disciplines in computer science, with AI focusing on the creation of computer systems capable of executing tasks that would typically need human intelligence. ML, being a sub-field of AI, emphasizes the implementation of algorithms and statistical models that allow computers to learn from and make predictions or decisions using data. Illustratively, Eurofins Discovery, a France-based corporation servicing various sectors including pharmaceuticals, unveiled its innovative platform known as DiscoveryAI SAFIRE (Suite of ADMET Predictions for In Silico Refinement and Evaluation) in February 2024. This sophisticated platform uses proprietary datasets, AI, and ML to expedite drug discovery. SAFIRE is engineered to speed up the discovery of novel pharmaceuticals by predicting the ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties of molecules. It capitalizes on the data from Eurofins Discovery's comprehensive BioPrint database, exhaustively accumulated over years of research.

Which growth-oriented segments of the drug discovery services market are leading the industry's development?
The drug discovery services market covered in this report is segmented -

1) By Type: Chemistry Services, Biology Services
2) By Process: Target Selection, Target Validation, Hit-To-Lead identification, Lead Optimization, Candidate Validation
3) By Drug Type: Biologics Drug , Small Molecule Drug
4) By End user: Pharmaceutical And Biotechnology Companies, Academic Institutes, Other End Users

Subsegments:
1) By Chemistry Services: Medicinal Chemistry, Compound Management, High-Throughput Screening, Lead Optimization
2) By Biology Services: In Vitro Studies, In Vivo Studies, Pharmacokinetics And Pharmacodynamics (PK Or PD), Biomarker Discovery

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8324

What regions are leading the charge in the drug discovery services market?
North America was the largest region in the drug discovery services market in 2024. The regions covered in the drug discovery services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the drug discovery services market?
Major companies operating in the drug discovery services market are Thermo Fisher Scientific Inc., Albany Molecular Research Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, Domainex Ltd., GenScript Biotech Corporation, Pharmaceutical Product Development LLC, Advinus Therapeutics Pvt. Ltd., Jubilant Biosys Ltd., Evotec AG, Syngene International Ltd., Bayer AG, Merck KGaA, Ubiquigent Ltd., Eurofins Scientific SE, AppTec Laboratory Services Inc., GVK Biosciences Private Limited, Aurigene Discovery Technologies Limited, Viva Biotech Holdings, Pharmaron Beijing Co. Ltd., Selcia Limited, Concept Life Sciences Group Limited, BioDuro LLC, ChemPartner Corporation, Aptuit LLC, Sygnature Discovery Limited, Peak Proteins Ltd., SRI International, BioAscent Discovery Limited, Sai Life Sciences Limited, Promega Corporation, MedChemExpress LLC, Aragen Bioscience Inc., WuXi STA, BioNTech SE, Moderna Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Amgen Inc., Bristol-Myers Squibb Company

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8324&type=smp

What Is Covered In The Drug Discovery Services Global Market Report?

• Market Size Forecast: Examine the drug discovery services market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the drug discovery services market for a structured understanding.
• Key Players Overview: Analyze major players in the drug discovery services market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the drug discovery services market.
• Segment Contributions: Evaluate how different segments drive overall growth in the drug discovery services market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the drug discovery services market.
• Industry Challenges: Identify potential risks and obstacles affecting the drug discovery services market.
• Competitive Landscape: Review strategic developments in the drug discovery services market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.